Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_175
Snippet: HER2/neu is an epidermal growth factor receptor tyrosine kinase that is expressed in human cancers of the prostate, breast, ovary, stomach, and colon. HER2/neu expression is reported in up to 60% of human pediatric osteosarcomas, where increased expression correlates with aggressive biologic behavior and an increased risk of metastasis. Contrary to the membranous expression seen in carcinomas, HER2/neu expression in OSA is principally cytoplasmic.....
Document: HER2/neu is an epidermal growth factor receptor tyrosine kinase that is expressed in human cancers of the prostate, breast, ovary, stomach, and colon. HER2/neu expression is reported in up to 60% of human pediatric osteosarcomas, where increased expression correlates with aggressive biologic behavior and an increased risk of metastasis. Contrary to the membranous expression seen in carcinomas, HER2/neu expression in OSA is principally cytoplasmic. In canine patients, one previous retrospective study reported HER2 expression in 4/10 primary tumor samples, with a suggestion that HER2 expression correlated with decreased survival. We therefore hypothesized that HER2 expression in canine OSA denotes a more aggressive disease phenotype.
Search related documents:
Co phrase search for related documents- growth factor and HER2 neu expression: 1
- growth factor and human cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- growth factor and increase expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- growth factor and increase risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- growth factor and membranous expression: 1
- growth factor and neu expression: 1, 2
- growth factor and retrospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- growth factor and tyrosine kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- HER2 expression and human cancer: 1, 2, 3, 4
- HER2 expression and increase expression: 1
- HER2 expression and neu expression: 1, 2, 3, 4, 5, 6
- HER2 expression and tyrosine kinase: 1
- HER2 neu expression and neu expression: 1, 2, 3, 4, 5, 6
- human cancer and increase expression: 1, 2, 3, 4, 5, 6, 7, 8
- human cancer and increase risk: 1, 2, 3, 4
- human cancer and retrospective study: 1, 2
- human cancer and tumor sample: 1
- human cancer and tyrosine kinase: 1, 2, 3, 4
- increase expression and retrospective study: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date